CIK: 0001668343 · Show all filings
Period: Q4 2025 (← Previous)
Filing Date: Feb 17, 2026
Total Value ($000): $16,587 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| IONQ | IonQ, Inc. | 9,521 | $427 | 2.6% | $56.04 | 0.0% | CL A | 46222L108 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RXRX | Recursion Pharmaceuticals, Inc. | 3,951,141 | $16,160 | 97.4% | $18.82 | -73.7% | CL A | 75629V104 |